Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Determine which no fee travel card is better suited for you. Make the right choice for your travel goals and preferences.
22,600 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Want a reliable, growing paycheck from your first $1,000? This guide shows how to spot the ultimate dividend growth s...
As Innventure gears up for its 2025 earnings report, investors seek clarity on growth, burn rate, and cash runway. Th...
South Korea authorities indict five individuals in what prosecutors call the first DEX rug pull case under the 2024 V...
Kingsoft Cloud KC 2026 Q1 sets the tone for the year. This guide breaks down what to watch in margins, segments, and ...
A $600,000 annuity pays $3,700 a month in guaranteed income, but a spouse’s needs and legacy goals can change the mat...
Uber is dialing back its push on wide AI bets, choosing measured investments aimed at ROI and platform reliability. T...
President Trump taps Bill Pulte to serve as Acting Director of National Intelligence while keeping him at the helm of...
Micron Technology is at a pivotal moment as AI-related demand collides with a cyclical memory market. Shares have sur...
May delivered a powerful rally for chip stocks. This article explains why ishares semiconductor (SOXX) jumped 23% and...
A major payer shift could unlock stronger demand for Eli Lilly’s obesity and GLP-1 products. This in-depth analysis e...
Mega IPOs attract huge attention, but history teaches a sober lesson about valuation, timing, and long-term returns. ...